SCHEMBL19081684

SCHEMBL19081684

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)oc4ccc6oc7c8ccccc8ccc7c6c45)c4ccccc34)cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 4/20 0.33
ABCG2 Q9UNQ0 4/20 0.33
ABCC1 P33527 3/20 0.33
ARSA P15289 1/20 0.33
CDC25A P30304 1/20 0.33
CDC25C P30307 1/20 0.33
CYP1A1 P04798 9/20 0.33
CYP1B1 Q16678 9/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 8/20 0.32
PSMD14 O00487 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PRKDC P78527 1/20 0.32
XDH P47989 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127518 0.91 ARSA (0.36) ABCB1ABCG2ABCC1ARSACDC25A
SCHEMBL20127575 0.91 ABCG2 (0.35) ABCG2CYP1A1KMT2ACYP1A2TDP1
SCHEMBL19081680 0.90 AHR (0.32) ABCG2ARSACDC25ACDC25CCYP1A1
SCHEMBL19080967 0.90 ARSA (0.33) ABCB1ABCG2ABCC1ARSACDC25A
SCHEMBL19081675 0.89 ARSA (0.35) ABCB1ABCG2ABCC1ARSACDC25A
SCHEMBL20127585 0.88 ABCG2 (0.34) ABCG2CYP1A1KMT2ACYP1A2TDP1
SCHEMBL10122702 0.88 ABCG2 (0.34) ABCG2CYP1A1KMT2ACYP1A2TDP1
SCHEMBL10122700 0.88 ABCG2 (0.34) ABCG2CYP1A1KMT2ACYP1A2TDP1
SCHEMBL20127525 0.88 ARSA (0.34) ABCB1ABCG2ABCC1ARSACDC25A
SCHEMBL17122632 0.88 ARSA (0.35) ABCB1ABCG2ABCC1ARSACDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCB1 3875/4885ABCG2 4823/4885ABCC1 3301/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCB1 3875/4885ABCG2 4823/4885ABCC1 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.